CHARACTERIZATION OF P53 GENE-MUTATIONS IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMA CELL-LINES - INCREASED FREQUENCY AND DIFFERENT SPECTRUM OF MUTATIONS FROM PRIMARY TUMORS

Citation
H. Tanaka et al., CHARACTERIZATION OF P53 GENE-MUTATIONS IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMA CELL-LINES - INCREASED FREQUENCY AND DIFFERENT SPECTRUM OF MUTATIONS FROM PRIMARY TUMORS, International journal of cancer, 65(3), 1996, pp. 372-376
Citations number
21
Categorie Soggetti
Oncology
ISSN journal
00207136
Volume
65
Issue
3
Year of publication
1996
Pages
372 - 376
Database
ISI
SICI code
0020-7136(1996)65:3<372:COPGIE>2.0.ZU;2-Z
Abstract
We screened 29 human esophageal squamous cell carcinoma (ESC) cell lin es for mutations of the p53 gene through all coding exons and exon-int ron junctions. Mutations were found in 22 cell lines (76%), consisting of 20 single-base substitutions, 2 small deletions and 1 single-base insertion. Out of 20 single-base substitution, 5 were located at the e xon-intron junctions and mRNAs with abnormal splicing were detected by RT-PCR in 4 of them. A G:C to T:A transversion, which occurred rather frequently in resected tumors of ESC, was observed in only I cell lin e, and, instead, frequent transitions at CpG sites were detected. We a lso examined 65 fresh tumor materials, from all of which we tried to e stablish cell lines, and detected mutations in 26 samples (40%). Compa red with the results in these fresh tumor materials, the mutation inci dence In cell lines was significantly high and the mutation spectrum w as also different. From these 65 tumors, 10 cell lines were establishe d, including 3 cell lines from 26 tumors with p53 mutations and 7 cell lines from 39 without mutations, which indicates that there was no si gnificant correlation between the status of the p53 gene in each fresh tumor and its establishment as a cell line. In 7 cell lines establish ed from mutation-free tumors, newly acquired mutations were detected i n 5, which suggests that mutations might occur during the process of e stablishing cell lines. (C) 1996 Wiley-Liss, Inc.